Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | CCR6 | P51684 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11839693 | 0.91 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2POLBMAPTHPGD | |
| SCHEMBL16350574 | 0.81 | ALDH1A1 (0.81) | ALDH1A1SMN1; SMN2POLBMAPTHPGD | |
| SCHEMBL362773 | 0.81 | ALDH1A1 (0.65) | ALDH1A1SMN1; SMN2POLBMAPTHPGD | |
| SCHEMBL11016895 | 0.81 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2POLBDPP4 | |
| SCHEMBL3305715 | 0.79 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2POLBMAPTHPGD | |
| SCHEMBL6160104 | 0.79 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2POLBMAPTHPGD | |
| SCHEMBL5485685 | 0.79 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2POLBMAPTHPGD | |
| SCHEMBL8068413 | 0.77 | ALDH1A1 (0.91) | ALDH1A1SMN1; SMN2POLBMAPTHPGD | |
| N,N-Diallyl-2-Chloroacetamide SCHEMBL4886939 | 0.77 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2POLBMAPTHPGD | |
| N,N-Diallyl-2-Chloroacetamide SCHEMBL53540 | 0.77 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2POLBMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050065118-A1 | Organosulfur inhibitors of tyrosine phosphatases | METABASIS THERAPEUTICS, INC. | 2005-03-24 | — | — | US | claimed |
| EP-1446110-A2 | ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES | Structural Bioinformatics Inc. (US) | 2004-08-18 | — | — | EP | claimed |
| WO-2003032916-A2 | ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES | STRUCTURAL BIOINFORMATICS INC. (US) | 2003-04-24 | — | — | WO | claimed |
| US-4334073-A | BASIC CATALYSTS, DEACETYLATION, ESTERIFICATION | BAYER AKTIENGESELLSCHAFT (DE) | 1982-06-08 | — | — | US | claimed |
| US-20050065118-A1 | Organosulfur inhibitors of tyrosine phosphatases | METABASIS THERAPEUTICS, INC. | 2005-03-24 | — | — | US | disclosed |
| EP-1446110-A2 | ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES | Structural Bioinformatics Inc. (US) | 2004-08-18 | — | — | EP | disclosed |
| WO-2003032916-A2 | ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES | STRUCTURAL BIOINFORMATICS INC. (US) | 2003-04-24 | — | — | WO | disclosed |
| US-4757113-A | Blending resin carrying functional groups reactive with isocyanate group with a blocked polyisocyanate compound reactive in the presence of heat with above functional groups to provide crosslinking | VIANOVA KUNSTHARZ, A. G. (AT) | 1988-07-12 | — | — | US | disclosed |
| US-4009192-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DT) | 1977-02-22 | — | — | US | disclosed |
| US-3932448-A | FUNGICIDES, MITICIDES | E. I. DU PONT DE NEMOURS & COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065118-A1 | Organosulfur inhibitors of tyrosine phosphatases | PTPRS, PTPRJ, PTPRCAP | ALDH1A1 961/4885SMN1; SMN2 2211/4885POLB 3621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.